Actively Recruiting
Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
Led by VA Office of Research and Development · Updated on 2025-10-22
250
Participants Needed
2
Research Sites
147 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cardiac rehabilitation (CR) is a secondary prevention program for patients with cardiovascular disease (CVD). It is especially valuable as CVD increasingly occurs in combination with comorbidity, frailty, and complexities of care that predispose patients to functional decline, disability, and high costs. Still, few Veterans participate in CR, in part because of the difficult logistics to attend. Promising Practice home-based CR (HBCR) was developed to increase CR participation, but many Veterans remain too limited by comorbidity and frailty for participation. A Transition to CR (T2CR) intervention is a face-to-face program that fosters vital skills, education, insights, motivation, and patient-provider relationships conducive to successful HBCR thereafter. This study compares Veterans eligible for CR who are randomized to T2CR intervention versus usual care. Differences in functional capacity, HBCR participation, and healthy days at home are compared over one year. Patients' experiences and providers' perspectives of barriers and facilitators to T2CR are also compared.
CONDITIONS
Official Title
Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female Veterans hospitalized with ischemic heart disease (acute myocardial infarction or stable ischemia)
- Veterans hospitalized with revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
- Veterans hospitalized with valvular heart disease (surgical or percutaneous intervention for mitral regurgitation or aortic stenosis)
- Veterans hospitalized with heart failure (with reduced or preserved ejection fraction)
- Willingness to consider cardiac rehabilitation as a treatment option, including possible extension of hospitalization by up to 2 days
- English speaking
- Able to provide written informed consent
You will not qualify if you...
- Unstable medical condition or end-stage disease likely fatal within 12 months
- Severe cognitive impairment (MiniCog score 0-2)
- History of addictive or behavioral issues that interfere with safe home-based cardiac rehabilitation
- Hearing loss interfering with trial participation
- Living in long-term care prior to hospitalization with no plans to return to independent living
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, United States, 02130-4817
Actively Recruiting
2
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, United States, 15240
Actively Recruiting
Research Team
D
Daniel E Forman, MD
CONTACT
G
Greg A Owens, BA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here